[Federal Register Volume 75, Number 123 (Monday, June 28, 2010)]
[Notices]
[Pages 36694-36695]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-15530]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration

    By Notice dated March 16, 2010, and published in the Federal 
Register on March 24, 2010 (75 FR 14186), Roche Diagnostics Operations 
Inc., Attn: Regulatory Compliance, 9115 Hague Road, Indianapolis, 
Indiana 46250, made application by renewal to the Drug Enforcement 
Administration (DEA) to be registered as an importer of the basic 
classes of controlled substances listed in schedules I and II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Lysergic acid diethylamide (7315)..........  I
Tetrahydrocannabinols (7370)...............  I
Alphamethadol (9605).......................  I
Cocaine (9041).............................  II
Ecgonine (9180)............................  II
Methadone (9250)...........................  II
Morphine (9300)............................  II
------------------------------------------------------------------------

    The company plans to import the listed controlled substances for 
the manufacture of diagnostic products for distribution to its 
customers.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and 952(a), and determined that the 
registration of Roche Diagnostics Operations Inc. to

[[Page 36695]]

import the basic classes of controlled substances is consistent with 
the public interest, and with United States obligations under 
international treaties, conventions, or protocols in effect on May 1, 
1971, at this time. DEA has investigated Roche Diagnostics Operations 
to ensure that the company's registration is consistent with the public 
interest. The investigation has included inspection and testing of the 
company's physical security systems, verification of the company's 
compliance with state and local laws, and a review of the company's 
background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 
958(a), and in accordance with 21 CFR 1301.34, the above named company 
is granted registration as an importer of the basic classes of 
controlled substances listed.

    Dated: June 17, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2010-15530 Filed 6-25-10; 8:45 am]
BILLING CODE 4410-09-P